Dareway(SH:688579)2023-04-13 16:00Financial Performance - The company's operating revenue for 2022 was ¥453,909,101.18, a decrease of 28.80% compared to ¥637,509,880.44 in 2021[23]. - The net profit attributable to shareholders for 2022 was ¥61,912,476.23, down 39.95% from ¥103,100,055.19 in 2021[23]. - The net cash flow from operating activities decreased by 58.16% to ¥39,924,845.63, compared to ¥95,414,884.45 in the previous year[25]. - The basic earnings per share for 2022 was ¥0.1548, a decline of 39.93% from ¥0.2577 in 2021[24]. - The total assets at the end of 2022 were ¥1,687,169,158.93, a decrease of 1.98% from ¥1,721,172,342.90 at the end of 2021[23]. - The weighted average return on net assets for 2022 was 4.82%, down 3.48 percentage points from 8.30% in 2021[24]. - The net profit after deducting non-recurring gains and losses was ¥45,923,636.33, a decrease of 46.27% from ¥85,474,815.72 in 2021[23]. - The decline in performance was primarily attributed to the macroeconomic environment affecting project execution and delivery schedules[25]. Research and Development - The R&D expenditure as a percentage of operating revenue increased to 28.50%, up 9.68 percentage points from 18.82% in 2021[24]. - Research and development expenses for 2022 amounted to CNY 12,936.63 million, reflecting a 7.82% increase from the previous year[37]. - The total R&D investment reached approximately ¥129.37 million, a 7.82% increase from the previous year, with R&D expenses accounting for 28.50% of operating revenue[85]. - The capitalized R&D investment increased by 25.91% year-over-year, indicating a strategic focus on long-term innovation[85]. - The company has received 9 new invention patents and 65 software copyrights during the reporting period, totaling 34 patents and 420 copyrights by December 31, 2022[81]. Corporate Governance - The company has confirmed that all board members attended the board meeting, ensuring accountability for the report's accuracy[5]. - The company has not reported any instances of more than half of the board members being unable to guarantee the report's authenticity[8]. - The company has maintained a governance structure that ensures independence from its controlling shareholders[180]. - The company held its annual general meeting on May 6, 2022, where all resolutions were approved without any objections[174]. - The company’s independent directors attended all board meetings and shareholder meetings without any absences[198]. Market and Business Strategy - The company plans to distribute a cash dividend of RMB 0.50 per 10 shares, totaling approximately RMB 20,000,500 (including tax) for the 2022 fiscal year[5]. - The company is focusing on expanding its market presence outside Shandong Province, with new orders signed in regions like the Yangtze River Delta and Pearl River Delta[124]. - The company aims to become a leading "AI + Blockchain" technology service provider in China, focusing on smart social security, smart healthcare, and intelligent electricity sectors[167]. - The company plans to enhance project delivery management to achieve rapid growth in operating performance, with historical highs in unconfirmed orders and gross profit at the end of the reporting period[168]. - The company is exploring potential acquisitions to enhance its service offerings, with a budget of RMB 200 million allocated for this purpose[190]. Technological Advancements - The company launched the EasyAI platform and a low-code platform to support cloud-native application development, enhancing its technological capabilities[36]. - The company is focusing on cloud computing, DevOps, and low-code platforms as new software service models, which are essential for optimizing resource allocation and enhancing software delivery efficiency[71]. - The company is committed to continuous innovation in blockchain and data element solutions, addressing various digital application scenarios and enhancing its market presence[76]. - The company has achieved significant advancements in artificial intelligence applications in the healthcare sector, enhancing patient experience and satisfaction through intelligent diagnosis and personalized treatment[70]. - The company has developed a digital asset public service platform based on blockchain technology, aimed at improving competitiveness and driving blockchain industry development[92]. Financial Risks and Management - The company faces risks related to the rapid technological upgrades in the software and information technology service industry, particularly with the rise of AI technologies like ChatGPT[122]. - The company's accounts receivable and contract assets totaled 350.06 million yuan, indicating potential liquidity risks if accounts receivable management is not handled properly[130]. - The company anticipates potential adverse impacts on its operating performance and profit levels if it fails to maintain its status as a high-tech enterprise or if favorable tax policies change[132]. - The company reported a significant decrease of 83.84% in payable taxes, totaling 2,873,988.47 RMB, due to tax payments made during the period[156]. - The company has a low debt-to-asset ratio, indicating a stable financial foundation despite facing competition from larger firms in the industry[125]. Future Outlook - The company reported a total revenue of RMB 1.2 billion for the fiscal year 2022, representing a year-over-year growth of 15%[190]. - The company has set a revenue guidance of RMB 1.5 billion for the next fiscal year, projecting a growth rate of 25%[190]. - New product launches are expected to contribute an additional RMB 300 million in revenue, with a focus on innovative software solutions[190]. - The company is investing RMB 100 million in R&D for new technologies aimed at enhancing user experience and operational efficiency[190]. - Future guidance indicates a positive outlook with expectations of continued revenue growth in the upcoming fiscal year[184].